Seliger B et al. showed that the methylation of the UCHL1 DNA promoter leads to UCHL1 silencing in both ccRCC cell lines and primary lesions, mainly of clear cell subtype. This evidence concerns the gene UCHL1 and nonpapillary renal cell carcinoma.